Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Market Cap: 64.88M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 64.88M |
| May 16, 2024 | 66.06M |
| May 15, 2024 | 68.10M |
| May 14, 2024 | 66.60M |
| May 13, 2024 | 65.52M |
| May 10, 2024 | 66.27M |
| May 09, 2024 | 73.27M |
| May 08, 2024 | 69.72M |
| May 07, 2024 | 69.07M |
| May 06, 2024 | 73.70M |
| May 03, 2024 | 66.17M |
| May 02, 2024 | 59.07M |
| May 01, 2024 | 57.99M |
| April 30, 2024 | 54.87M |
| April 29, 2024 | 53.04M |
| April 26, 2024 | 59.17M |
| April 25, 2024 | 58.74M |
| April 24, 2024 | 57.88M |
| April 23, 2024 | 62.08M |
| April 22, 2024 | 61.54M |
| April 19, 2024 | 57.45M |
| April 18, 2024 | 62.08M |
| April 17, 2024 | 64.45M |
| April 16, 2024 | 64.55M |
| April 15, 2024 | 64.23M |
| Date | Value |
|---|---|
| April 12, 2024 | 68.75M |
| April 11, 2024 | 71.76M |
| April 10, 2024 | 83.27M |
| April 09, 2024 | 83.49M |
| April 08, 2024 | 83.81M |
| April 05, 2024 | 83.49M |
| April 04, 2024 | 77.68M |
| April 03, 2024 | 92.96M |
| April 02, 2024 | 98.44M |
| April 01, 2024 | 102.32M |
| March 28, 2024 | 94.52M |
| March 27, 2024 | 105.05M |
| March 26, 2024 | 107.74M |
| March 25, 2024 | 106.55M |
| March 22, 2024 | 114.39M |
| March 21, 2024 | 96.99M |
| March 20, 2024 | 94.52M |
| March 19, 2024 | 80.45M |
| March 18, 2024 | 106.98M |
| March 15, 2024 | 93.45M |
| March 14, 2024 | 78.95M |
| March 13, 2024 | 74.01M |
| March 12, 2024 | 82.71M |
| March 11, 2024 | 67.88M |
| March 08, 2024 | 88.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.96M
Minimum
Oct 31 2023
244.84M
Maximum
Mar 17 2021
86.38M
Average
67.86M
Median
Jan 21 2022
Market Cap Benchmarks
| Eyenovia Inc | 40.40M |
| Cassava Sciences Inc | 1.109B |
| Alpine Immune Sciences Inc | 4.457B |
| Clearside Biomedical Inc | 97.90M |
| Poseida Therapeutics Inc | 309.30M |
Market Cap Related Metrics
| Price to Book Value | 1.814 |
| Price | 6.13 |
| Earnings Yield | -27.03% |